German Cancer Research Center To Use Febit Analyzer for miRNA Studies | GenomeWeb
NEW YORK (GenomeWeb News) – The German Cancer Research Center, or DFKZ, will use Febit’s Geniom RT Analyzer for its research into the roles of microRNAs in cancer, Febit said today.
Heidelberg-based DFKZ will use the Geniom RT analyzer for microarray analysis of miRNA profiles in biological samples.
Febit said the system can be used to fragment and sort large genomes into smaller fractions, which may then be used as samples in mutation analysis and high-throughput sequencing studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.